Brief: Alembic Pharmaceuticals Gets US FDA Tentative Approval For Selexipag For Injection
12/07/2024 12:34
July 12 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* RECEIVES USFDA TENTATIVE APPROVAL FOR SELEXIPAG FOR
INJECTION,
1,800 MCG/VIAL.
Source text for Eikon: ID:nBSE7TKb4D
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand